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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not
electrical muscle stimulation is effective in the progression of oral feeding, for patients with
dysphagia, caused by a stroke.
STUDY DESIGN: Review of 3 randomized controlled trials, published between 2008-2009.
DATA SOURCES: All 3 randomized controlled trials were found using the Cochrane database.
OUTCOMES MEASURED: All 3 studies measured subjective swallowing function pre- and
post-treatment, however, each trial differed in the way they measured this. Permsirivanich et al
used a functional oral intake scale (FOIS), or a 7-point scale reflecting the patient’s report of
foods safely ingested by mouth, on a consistent basis. Bulow et al determined swallowing
function using an alternate 7-point scale, called the actual nutrition scale (ANS). Lim et al
measured swallowing function using a third, unnamed, 7-point scale. The percentage of patients
progressing from tube feeding to oral feeding was also measured in Lim et al.
RESULTS: Bulow et al concluded that no statistically significant difference was found in the
therapy effects between neuromuscular electrical stimulation (NMES) and traditional therapy
(TT) groups, however, when looking at both groups as a whole, there were significant
improvements noted. In Permsirivanich et al, both rehabilitation swallowing therapy (RST) and
NMES therapy (combined with diet modification and oral motor exercises) showed positive
effects in the treatment of persistent dysphagia in stroke patients, but NMES therapy was
significantly superior. Finally, in Lim et al, NMES combined with thermal tactile stimulation
(TTS) had a significantly higher score change in swallowing measures (indicating a progression
of oral feeding) than those receiving TTS alone.
CONCLUSION: As indicated by the 3 studies, NMES therapy, as an adjunct treatment to
standard dysphagia treatment, is an effective intervention in the progression of oral feeding, in
patients with dysphagia, caused by a stroke. Further studies should be performed to determine if
NMES is a valuable therapy alone, or only advantageous when paired with a traditional therapy.
KEY WORDS: “dysphagia”, “stroke”, “electrical muscle stimulation”
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INTRODUCTION:
The seemingly simple act of swallowing is actually a very complex process that is
initiated by the cerebral cortex and followed through by the brain stem. When these specific
areas of the brain are injured, such as in a stroke, the act of swallowing is disrupted (known as
dysphagia) and the airway becomes vulnerable.1 In fact, 45-65% of all acute stroke patients,
which accounts for approximately 3.3 million healthcare visits annually2, will develop
dysphagia. Dysphagia leaves patients at risk for aspiration, because the muscles and nerves
surrounding the oropharynx are not able to aid in safely transporting food from the mouth into
the stomach. Aspiration can then lead to aspiration pneumonia, which accounts for
approximately 34% of stroke related deaths, as well as causing complications such as choking,
bronchospasm, increased infection rate, dehydration and nutritional compromise.1 Dysphagia can
also have a negative social impact and thus affect one’s quality of life.
While the majority of stroke survivors have a return to normal swallowing function fairly
rapidly after a cerebral vascular accident, this is not always the case, and thus healthcare
providers must recognize the high healthcare costs of stroke survivors suffering from dysphagia.
While it is not known what the exact healthcare costs may be, it has been proven that dysphagia
after stroke lengthens hospital stays, thus carrying substantial economic burdens. In fact, Altman
et al3 found that in patients with hemorrhagic stroke, hospital stays increased from 4.74 days, in
those without dysphagia, to 10.55 days, in those suffering from dysphagia. Obviously, the longer
the hospital stay, the greater the cost.
Fortunately, the majority of healthcare workers are aware of dysphagia and its negative
impact on one’s health, as well as its economic burden, thus, making it a topic of study in the
medical community. Presently, there are a few successful methods used to treat dysphagia post-
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CVA. Diet modification and specific exercises designed to strengthen the muscles surrounding
the swallowing apparatus are two simple methods currently used.4 Thermal-tactile stimulation
(TTS), which involves stroking a patient’s anterior faucial pillars with a cold probe prior to
swallowing, is an alternate technique used.1 Yet another approach is rehabilitation swallowing
therapy (RST), which includes supraglottic swallowing, effortful swallowing and the
Mandelsohn maneuver, or purposeful prolongation, mid-swallow, of anterosuperior laryngeal
traction.5 Current research is proposing electrical muscle stimulation, or neuromuscular electrical
stimulation (NMES), which uses electrodes to deliver electrical stimulation to muscles, in turn
causing muscle contraction by the depolarization of nerve fibers, and an increase in muscle
strength, to aid in the treatment of dysphagia.1 A few studies have shown favorable effects of
NMES on the symptoms of dysphagia, including reorganization of the human motor cortex, but
studies are still being preformed on how pharyngeal function is truly affected by NMES.4 This
review analyzes three randomized controlled trials which address NMES therapy versus control
therapy, in the progression of oral feeding, in stroke patients suffering from dysphagia.
OBJECTIVE:
The objective of this selective EBM review is to determine whether or not electrical
muscle stimulation is effective in the progression of oral feeding, for patients with dysphagia,
caused by a stroke.
METHODS:
The studies included in this review were found within the Cochrane database, after
preforming an advanced search with the following parameters: only articles published in English,
studies published after 2006 and the exclusion of previously published meta-analysis or
systematic reviews. The key words “dysphagia”, “stroke” and “electrical muscle stimulation”
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were used to search for relevant studies. Published articles were then selected based on relevance
to the topic and how the outcomes were measured: disease oriented evidence (DOE) was
excluded, while patient oriented evidence that matters (POEM) was included. Inclusion criteria
comprised of stroke survivors who were medically stable and able to elicit some pharyngeal
swallowing. Exclusion criteria included patients with neurologic disease other than a stroke, as
well as patients unable to receive treatment for a minimum of 1 hour in duration. Furthermore,
the studies needed to be randomized and controlled and could not involve patients under 18 years
old, or involve patients with dysphagia not caused by a stroke.
The 3 articles chosen for this review are all randomized controlled trails, each of which
compare the efficacy of NMES alone or with diet modification and/ or oral motor exercises,
versus a traditional therapy. The intervention in each study is electrical muscle stimulation, while
the comparisons are traditional therapies (including TTS, RST, diet modification, clinician
determined appropriate maneuvers or other treatment techniques). The outcomes measured
include either subjective swallowing function or tube to oral feeding progression, post- therapy.
The population studied across all three articles is adults over 18 years of age with mild to severe
dysphagia caused by a stroke. A summary of the statistics reported or used includes: p-values,
RBI, ABI and NNT. The demographics of included studies can be found in Table 1.
Table 1: Characteristics and Demographics of Included Studies.
Study

Type

Bulow4
(2008)

RCT

#
of
pts
25

Age

Inclusion criteria

Exclusion criteria

W/D

Interventions

50-80
(mean
age 70
for
NMES
and 71
for TT
group)

-Patients 50-80 y/o
with CVD >3
months prior to the
study
-Patients with
hemispheric stroke
and without
neurologic signs

-Patients with
progressive CVD,
other neurologic
diseases or neoplastic
disease of the
swallowing apparatus
and radiotherapy to
the neck

N/A

Neuromuscular
electrical
stimulation
(NMES),
using a handheld electrical
stimulator
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typical for brainstem
involvement
-Patients had to be
able to elicit some
pharyngeal
swallowing
-Patients had to be
able to communicate
Permsiri
vanich5
(2009)

Single
blind
RCT

23

>18
(64.73
+ 9.39
for
RST;
64.50+
8.80
for
NMES
)

-Hospitalized stroke
survivors with
persistent dysphagia
for > 2 weeks
between November
2007 and September
2008.
-Video-fluoroscopic
study (VFSS)
finding that
indicated pharyngeal
dysphagia with safe
swallowing

Lim1
(2009)

RCT

28

>18
(mean
SD:
67.8
(8.1)
for
exp;
60.8
(12.3)
for
control
)

-Primary diagnosis
of stroke with MRI
or CT scans
-Confirmation of a
swallowing disorder
by videofluoroscopy
-Score of 21 or
greater on the
MMSE
-Medically stable at
the time of the study

-Patients who had
undergone surgery to
the swallowing
apparatus
-Patients who were
not able to elicit
pharyngeal swallow
-Patient with an NG
tube
N/A

-Inability to receive
the treatment for 1
hour
-A neurologic disease
other than a stroke or
behavioral disorder
that interfered with
administration of
therapy
-Current illness or
upper GI disease
-Inability to give
informed consent

(VitalStim®),
for one-hour
sessions, 5
days a week
for 3 weeks,
compared to
TT.
5

8

NMES, via
VitalStim®,
combined with
diet
modification
and oral motor
exercise, done
for 1 hour
sessions, for 5
consecutive
days with 2
days off for 4
week,
compared to
RST.
NMES, via
VitalStim®,
and TTS for 1
hour, 5 days a
week,
compared to
TTS alone.

OUTCOMES MEASURED:
As previously mentioned, the primary outcomes measured in each article included either
subjective swallowing function or tube to oral feeding progression. In Bulow et al4, nutritional
status via a 7-point scale, called the actual nutrition scale (ANS), was used to assess outcomes.
The 7-point scale is as follows: 0= full oral, no limitations; 1= full oral, with compensation; 2=
full oral, with consistency restriction; 3= full oral, with compensation and consistency restriction;
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4= partial oral; 5= partial oral, with compensation; 6= tube feeding. In Permsirivanich et al5,
outcomes were assessed based on changes in functional oral intake via the Functional Oral Intake
Scale (FOIS), a 7-point scale reflecting the patient’s report of food/ liquids safely ingested by
mouth on a consistent basis. The FOIS scale is as follows: 1= nothing my mouth; 2= tube
dependent with minimal attempts of food or liquid; 3= tube dependent with consistent oral intake
of food or liquid; 4= total oral diet of a single consistency; 5= total oral diet with multiple
consistencies but requiring special preparation; 6= total oral diet with multiple consistencies
without special preparation, but with specific food limitations; 7= total oral diet with no
restriction. Finally, Lim et al1 looked at both tube feeding to oral progression and swallowing
function, via an alternate 7 point scale, which is as follows: 0= nothing safe (aspirated saliva); 1=
saliva; 2= pudding, paste, ice slush; 3= honey consistency; 4= nectar consistency; 5= thin
liquids; 6= water.
RESULTS:
The results obtained in all three studies were presented as continuous data. In
Permsirivanich et al5 and Lim et al1, some of the data could be successfully converted to
dichotomous form. However, this was not a possibility in Bulow et al4.
The study conducted by Bulow et al4 used the ANS mentioned above to compare
traditional swallowing therapy (TT), conducted for 60 minutes, 5 days a week for 3 weeks versus
NMES done for 60 minutes, 5 days a week for 3 weeks. Twenty-five patients over the age of 18
were included, with 12 randomized to the NMES group and 13 to TT. All subjects received 15
therapy sessions, regardless of the group they were randomized to. There was not a significant
loss to follow-up in this study, which indicates a loss of < 20%. Table 2, taken directly from
Bulow et al4, summarizes the results, which compares median (as well as 25th and 75th percentile)
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pre- and post-treatment ANS scores. The data is continuous and could not be converted to
dichotomous data. The median post-treatment minus pre-treatment ANS score was 0 for NMES
plus TT therapy, as well as TT therapy alone, and -1 for NMES therapy alone. Using the
Wilcoxon signed rank test to examine this data, Bulow et al4 found the data to be statistically
significant, with a p-value of .002 (a p-value < 0.05 indicates statistical significance). However,
when the therapy effects between the NMES group and the TT group were compared using the
Mann-Whitney test, there were no statistically significant differences found between the groups,
as indicated by a p-value of 0.189. 4
Table 2: Actual nutrition scale (ANS), comparisons pre- and post-treatment4
ANS

Pretreatment
Median
2.5
3.0
3.0

NMES
TT
NMES +
TT
*ns= not significant

th

th

25 ; 75
0.5; 5.8
0; 5.0
0: 5.0

N
12
13
25

Post minus pre-treatment
Median
25th; 75th
-1.0
-2.0: 0
0
-1.0; 0
0
-1.0: 0

pa
N
12
13
25

0.189 (ns)
0.002

In Permsirivanich et al5, change in functional oral intake was measured using the
functional oral intake scale (FOIS), mentioned above, in order to compare treatment outcomes
between RST and NMES intervention in stroke patients. Twenty-three patients enrolled in the
study were randomly split into a RST group of 11 and a NMES group of 12. While there were
originally 28 patients enrolled in the study, the losses (18%) did not constitute a significant loss.
All subjects received 60 minutes of either RST or NMES for 5 consecutive days, followed by 2
days off, then 5 additional consecutive days for a four-week period, until they reached a FOIS
level of 7. The summary of results can be found in Table 3 & Table 4. Table 3 illustrates
continuous data that was converted to dichotomous data. The data in Table 3, which uses the
percent of patients who managed total oral intake after therapy, in the RST (75%) versus the
NMES (90%) group, to determine relative benefit increase (RBI), absolute benefit increase
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(ABI) and number needed to treat (NNT) does indicate that treating 7 patients with dysphagia
post-stroke with NMES therapy, compared with RST, will have 1 additional patient achieve total
oral intake (as noted by the NNT of 7).
Permsirivanich et al5 also included mean FOIS score changes, post-treatment, for the
RST and NMES groups, which was presented as continuous data, as seen in Table 4. Using a ttest, the mean FOIS changes, for both the RST and NMES groups, were determined to be
statistically significant (p< .001), with the NMES therapy group attaining a greater mean FOIS
score change of 3.17 + 1.27 versus 2.46 + 1.04 in the RST group.
Table 3: Percentage of patients who managed total oral intake (FOIS levels 4-7) after therapy.
Total oral intake (FOIS levels 4-7) after
therapy.
RST
NMES
75%
90%

Relative Benefit
Increase (RBI)

Absolute Benefit
Increase (ABI)

Numbers Needed to
Treat (NNT)

20%

15%

7

Table 4: Mean FOIS score change post-treatment.5
Total oral intake (FOIS levels
4-7)
Mean FOIS change

RST

NMES therapy

p-value

2.46 + 1.04

3.17 + 1.27

<0.001

Finally, in Lim et al1, swallow function scores, based on the swallowing function scoring
system mentioned above, were calculated 4 weeks prior to treatment and 4 weeks post-treatment
for both the experimental group (NMES & TTS simultaneously) and the control group (TTS
only). The therapy sessions in both groups lasted for 1 hour on 5 of 7 days each week. Thirty-six
subjects entered the study, while 28 patients (16 in the experimental group and 12 in the control
group) with dysphagia completed the study, making the losses to follow-up > 20%, and thus a
significant loss. Lim et al1 stated that the main reason for patients not completing the study was
“early transfer to other hospital”. Table 5, taken directly from Lim et al1, includes a summary of
the initial, final and difference in the median swallow function scores, for the experimental and
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control group. While the table indicates a difference in the median initial swallow scores for the
control and experimental group (2 in the experimental versus 3 in the control), Lim et al1 states
“there was no difference between the 2 groups at initial evaluation”. However, it is evident in
Table 5, that the median value of swallow function scores in the experimental group changed
from 2 to 4, with a p-value <0.05 (as indicated by the Wilcoxon test), signifying a statistically
significant difference, while the control group changed from 3 to 4, with a p-value that was not
reported but stated to be “not significant”. As the study explains, “regarding the difference
between the initial and final swallow function score, patients in the experimental group had
significantly higher score changes than those in the control group”.
Tube feeding to oral-feeding progression was another parameter studied by Lim et al1.
Before the experiment, 7 out of 12 patients in the control group, and 12 out of 16 patients in the
experimental group, were receiving tube feeds. Following the respective interventions, only 1 of
the 7 patients in the control group progressed to oral feeds, while 6 out of the 12 patients in the
NMES & TTS group progressed. While this data was reported as continuous numbers in the
study, it was switched to dichotomous data for this review, as noted in Table 6. NNT was
calculated at 3, indicating that treating 3 patients with dysphagia post-stroke with NMES & TTS
combined compared with TTS alone will have 1 additional patient achieve progression from tube
to oral feeding, at 4 weeks after treatment.
Table 5: Median swallow function scores, using the swallowing function scoring system.1
Swallow Scores
Initial swallow scores
Final swallow scores
Difference in scores
after the treatment

Experimental Group
2
4*
2**

Control Group
3
4
1

*p<0.05 by Wilcoxon test between initial and final scores in the same group.
**p<0.05 by Mann-Whitney U test between experimental and control groups.
Table 6: Tube to oral feeding.
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Tube to oral feeding.
TTS alone
14%

NMES & TTS
50%

RBI

ABI

NNT

25.7%

36%

3

It is important to note that NMES therapy is a relatively safe intervention, with few
significant adverse reactions (more information regarding this can be found in the discussion
section below). Thus, the studies reviewed for this analysis did not mention much regarding
tolerability, or adverse events of therapy, and therefore will not be discussed here.
DISCUSSION:
The goal of this review was to investigate whether or not NMES therapy is effective in
the progression of oral feeding, in patients with dysphagia, caused by a stroke. Traditional
NMES therapy is perhaps most widely known for its role in muscle rehabilitation, post-injury,
because it helps to produce muscle contractions by exciting targeted motor nerves. Some of the
common conditions NMES is used for include sprains, strains, muscle weakness and atrophy.
The presence of healthy muscle tissue and peripheral nerve excitability are necessary in order to
produce therapeutic effects for these individuals.6 This same thought process is applied when
considering NMES for dysphagia. In dysphagia treatment, small, electrical impulses are
administered to the musculature overlaying the throat, while the patients exercises the
swallowing muscles, for up to 1 hour. It is postulated that this stimulation accelerates cortical
reorganization and increases muscle strength. However, traditional NMES electrodes are
contraindicated for use on the pharyngeal muscles due to the concern of causing laryngospasms
with stimulation of the laryngeal afferents, and the threat of sinus bradycardia if the electrodes
are too close to the carotid arteries.7 Therefore, electrodes, such as those found in the VitalStim®
Therapy System, have been developed for use specifically in the treatment of dysphagia. These
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electrodes should not be used over an active infection or neoplasm, and should be used
cautiously in individuals with seizure disorders or implanted electrical devices like pacemakers,
defibrillators, deep brain stimulators, etc. Furthermore, patients with lower motor neuron damage
or severely impaired cognition may not benefit as well as other patients from NMES treatment.7
It is also important to note that NMES therapy for dysphagia is FDA approved, and Medicare
provides reimbursement for treatment that is deemed medically necessary.7
Despite a lack of evidence, studies are currently being preformed, such as the 3
mentioned in this article, to better understand the role of NMES in the treatment of dysphagia,
caused by a stroke. NMES appears to play a significant role in the progression of oral feeding in
stroke patients suffering from dysphagia, yet its efficacy when used alone in treatment remains
unclear. Bulow et al4 concluded that no statistically significant difference was found in the
therapy effects between NMES and TT groups, however, when looking at both groups as a
whole, there were significant improvements noted. In Permsirivanich et al5, RST (including diet
modification, oral motor exercises, thermal stimulation and head and neck positioning) and
NMES therapy (combined with diet modification and oral motor exercises) showed a positive
effect in the treatment of persistent dysphagia in stroke patients, but NMES was significantly
superior. Finally, in Lim et al1, NMES combined with TTS (vs. TTS alone) had a significantly
higher score change in swallowing measures, than those in the control group.
In all 3 studies reviewed, there were several limiting factors, however. All articles1,4,5
included a relatively small number of subjects, with each comprising of less than 30 participants
by the conclusion of the studies. Furthermore, the length of follow up time was limited in all
studies1,4,5, with a 4 week or less follow-up period. More specific limitations were also found in
each individual study. In Bulow et al4, the authors indicated that patients were not stratified by
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hemispheric lesion, severity of CVA or time post-onset, which could have an effect on the
results. It can also be noted that although randomized, the baseline data for the NMES group was
more severe than those in the TT group. In Permsirivanich et al5, the number of total treatment
sessions, as well as the location of the NMES electrode placement, were not controlled for. In
Lim et al1, the participants loss to follow up was greater than 20%, undermining the validity of
the study. Also, the effects of swallowing physiology of changing variables of electrical
stimulation, like frequency and amplification, were not taken into account.
CONCLUSIONS:
In conclusion, electrical muscle stimulation is subjectively effective in the progression of
oral feeding, in stroke patients suffering from dysphagia, according to the three studies explored
in this paper. However, there is inconclusive evidence as the whether or not NMES therapy is
effective alone, or only in combination with TT, as demonstrated by Bulow et al4, or combined
with TTS, as seen in Lim et al1. Further studies should consider controlling for these variables by
having the experimental group receive only NMES therapy, versus NMES in combination with
another traditional therapy.
Furthermore, the validity of the results could be increased with a greater number of
subjects, as well as with long-term follow-up periods. Future studies might also consider
exploring the optimal duration time of each session, as well as total number of sessions for
NMES therapy, that would lead to optimal progression of oral feeding. Furthermore, it might be
interesting for future studies to evaluate the effect of variable frequencies and amplitudes of
NMES on swallowing physiology, just as Permsirivanich et al5 mentions.

REFERENCES:
1. Lim KB, Lee HJ, Lim SS, Choi YI. Neuromuscular electrical and thermal-tactile
stimulation for dysphagia caused by stroke: A randomized controlled trial. J Rehabil
Med. 2009;41(3):174-178. doi: 10.2340/16501977-0317.
2. Schappert S and Rechtsteiner E. Ambulatory medical care utilization estimates for 2007.
U.S. Department of Health and Human Services: Centers for Disease Contorl and
Prevention. 2011; Series 13, Number 169.
3. Altman K, et al. Consequences of dysphagia in the hospitalized patient: impact on
prognosis and resources. Arch Otolaryngol Head Neck Surg 2010; 136: 784-789.
4. Bulow M, Speyer R, Baijens L, Woisard V, Ekberg O. Neuromuscular electrical
stimulation (NMES) in stroke patients with oral and pharyngeal dysfunction. Dysphagia.
2008;23(3):302-309. doi: 10.1007/s00455-007-9145-9.
5. Permsirivanich W, Tipchatyotin S, Wongchai M, et al. Comparing the effects of
rehabilitation swallowing therapy vs. neuromuscular electrical stimulation therapy among
stroke patients with persistent pharyngeal dysphagia: A randomized controlled study. J
Med Assoc Thai. 2009;92(2):259-265.
6. Criterion Incorporated. NMES Treatment Protocols. Available at
http://www.criterionmed .com/ PDF/NMES%20Treatment%20Protocols.pdf.
Accessibility verified November 24, 2012.
7. VitalStim Therapy. What Is VitalStim? Available at http://www.vitalstim.com
/what_is_vitalstim/detail.aspx?id=88. Accessibility verified November 24, 2012.

